News
Discover a study that found that abobotulinum toxin A and prabotulinum toxin A demonstrated the quickest onset of action.
Hailing from South Korea, Letybo is the sixth and most recent neuromodulator approved by the FDA. Here, dermatologists unpack ...
2h
News-Medical.Net on MSNNew molecular mechanism offers hope for causal epilepsy treatmentsEpilepsy is primarily treated symptomatically - that is, the majority of the available medications aim to suppress seizures ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results